Category: Regulatory/FDA

EHRNEWS

FDA Draft Guidance for Real-world Data: Documentation of Data Approach Is Key

FDA-News (2)

FDA Issues BsUFA Commitment Letter, to Hold Public Meeting Nov. 2

EHRNEWS

Comment Now on FDA Draft Guidance on Use of EHR, Claims Data as RWD

vaccine.News

FDA, HRA Starting to Address Trial Investigator Result Reporting Lapses

CHC_FDA-Regulatory Images2

BMJ Study: Accelerated Approval Drugs Retain Status Despite Lack of Benefit

FDA-News (1)

OPDP Enforcement Letter to Eton Pharmaceuticals Cites Omission of Risk Info in Sponsored Links

CHC_FDA-Regulatory Images2

FDA Accepting Comment on Burden of Drug Advertising, HCEI Communications Disclosures

CHC_general2

OPDP To Study Impact of Exhibit Booth Materials, Medical Conference Conversations on HCPs

fda-logo

Amgen Gets OPDP Untitled Letter for Claims about Neulasta Onpro vs. PFS Delivery